11.04.2017 • News

Henrik Stenqvist Becomes Recipharm's New CFO

Recipharm has appointed Henrik Stenqvist as the company's new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. He will be based at the headquarters in Stockholm, Sweden and reports to CEO Thomas Eldered.

Henrik Stenqvist brings 24 years' finance and management experience to Recipharm. Prior to joining the Swedish pharma Contract Development and Manufacturing Organization (CDMO) he served as CFO of the Meda Group and held other leading finance positions in the pharmaceutical industry. He holds a degree in Finance and Business Administration from the University of Linkoeping, Sweden.

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Predictive Simulation in Pharma Production

When Every Temperature Change Determines the Process

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

most read

News • Chemistry

Orion Announced Plans to Shut Down Carbon Black Plants

Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.

News • Chemistry

CHEManager International Media Kit

Compelling solutions through strategic partnerships

Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring

Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.

News • Chemistry

BASF Sells Majority Stake in Coatings Business

BASF sells a majority stake in its coatings business to the investor Carlyle.

News • Bioprocessing

Merck Acquires Chromatography Business from JSR Life Sciences

Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.